Though Illumina s Q2 Revenues Increase 38 Percent, Stock Drops 14.7 Percent | GenomeWeb

NEW YORK, July 27 (GenomeWeb News) - Illumina yesterday reported increased revenues and losses for the second quarter of 2005.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.